Zhang ZB - Search Results

1

[Evidence mapping of clinical research on 20 Chinese patent medicines for hypertension].

Wang YF, Guo LJ, Gao F, Zhang ZB, Ren GC, Ma XC. Wang YF, et al. Among authors: zhang zb. Zhongguo Zhong Yao Za Zhi. 2022 Sep;47(18):5097-5105. doi: 10.19540/j.cnki.cjcmm.20220602.501. Zhongguo Zhong Yao Za Zhi. 2022. PMID: 36164920 Review. Chinese.

2

Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure.

Wang A, Zhao W, Yan K, Huang P, Zhang H, Zhang Z, Zhang D, Ma X. Wang A, et al. Front Pharmacol. 2022 Feb 24;13:810587. doi: 10.3389/fphar.2022.810587. eCollection 2022. Front Pharmacol. 2022. PMID: 35281941 Free PMC article. Review.

3

Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology.

Wang A, Li Z, Zhuo S, Gao F, Zhang H, Zhang Z, Ren G, Ma X. Wang A, et al. Front Cardiovasc Med. 2022 May 23;9:857952. doi: 10.3389/fcvm.2022.857952. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35677689 Free PMC article.

4

[Research Progress of Circular RNA in Lung Cancer].

Ge X, Zhang Z, Zhi X, Wang J. Ge X, et al. Zhongguo Fei Ai Za Zhi. 2020 Dec 20;23(12):1095-1100. doi: 10.3779/j.issn.1009-3419.2020.102.38. Zhongguo Fei Ai Za Zhi. 2020. PMID: 33357317 Free PMC article. Review. Chinese.

5

Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis.

Chen S, Zhang Z, Zheng X, Tao H, Zhang S, Ma J, Liu Z, Wang J, Qian Y, Cui P, Huang D, Huang Z, Wu Z, Hu Y. Chen S, et al. Front Oncol. 2021 Apr 16;11:562315. doi: 10.3389/fonc.2021.562315. eCollection 2021. Front Oncol. 2021. PMID: 33937012 Free PMC article.

6

Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.

Zhang Z, Li Y, Yan X, Song Q, Wang G, Hu Y, Jiao S, Wang J. Zhang Z, et al. Cancer Med. 2019 Apr;8(4):1467-1473. doi: 10.1002/cam4.2024. Epub 2019 Mar 7. Cancer Med. 2019. PMID: 30848091 Free PMC article.

7

Meta-analysis of PD-(L)1 inhibitor plus chemotherapy versus chemotherapy as first-line treatment in extensive-stage small-cell lung cancer.

Lu J, Lei X, Zhang P, Du L, Zhang Z, Qu B. Lu J, et al. Cancer Med. 2023 Sep;12(17):17924-17933. doi: 10.1002/cam4.6433. Epub 2023 Aug 11. Cancer Med. 2023. PMID: 37563966 Free PMC article.

8

Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors.

Chen S, Huang Z, Jia W, Tao H, Zhang S, Ma J, Liu Z, Wang J, Wang L, Cui P, Zhang Z, Huang D, Wu Z, Zheng X, Hu Y. Chen S, et al. J Hepatocell Carcinoma. 2020 Nov 2;7:289-299. doi: 10.2147/JHC.S277453. eCollection 2020. J Hepatocell Carcinoma. 2020. PMID: 33173757 Free PMC article.

9

Neuron - specific enolase predicts the prognosis in advanced small cell lung cancer patients treated with first-line PD-1/PD-L1 inhibitors.

Li L, Zhang Z, Hu Y. Li L, et al. Medicine (Baltimore). 2021 Sep 10;100(36):e27029. doi: 10.1097/MD.0000000000027029. Medicine (Baltimore). 2021. PMID: 34516493 Free PMC article.

10

Prognostic value of baseline and change in neutrophil-to-lymphocyte ratio for survival in advanced non-small cell lung cancer patients with poor performance status receiving PD-1 inhibitors.

Chen S, Li R, Zhang Z, Huang Z, Cui P, Jia W, Zhang S, Tao H, Wang L, Li X, Wang J, Ma J, Liu Z, Huang D, Zheng X, Saito Y, Ichiki Y, Hu Y. Chen S, et al. Transl Lung Cancer Res. 2021 Mar;10(3):1397-1407. doi: 10.21037/tlcr-21-43. Transl Lung Cancer Res. 2021. PMID: 33889518 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

563 results

Search Page

Filters